Skip to main content
Clinical Trials/NL-OMON56115
NL-OMON56115
Not yet recruiting
Not Applicable

PRIMARY: postoperative biomarker measurements after coronary bypass surgery; towards an improved understanding and definition of the concepts of periprocedural myocardial injury and infarction - PRIMARY

Medisch Universitair Ziekenhuis Maastricht0 sites143 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Periprocedural myocardial injury
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
143
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • \- Adult patients (\>18 years of age).
  • \- Surgery preceded by a heart\-team discussion, in which the patient is planned
  • for multivessel CABG, receiving more than one graft (i.e., more than only left
  • internal mammary artery \[LIMA] to left anterior descending artery \[LAD]).
  • \- Isolated on\-pump planned multivessel CABG (defined as using cardiopulmonary
  • bypass and cardioplegic arrest).
  • \- Able and willing to provide written informed consent.
  • \- Elective or urgent surgery (defined as either planned surgery, or a surgical
  • procedure without which the patients cannot leave the hospital before the
  • surgery is performed24\).

Exclusion Criteria

  • \- Non\-adult patients (\<18 years of age)
  • \- Emergency surgery (defined as within 24 hours of indication and not waiting
  • until the following working day24\).
  • \- Recent acute coronary syndromes (including ST\-elevation myocardial infarction
  • \[STEMI] and non\-STEMI \[NSTEMI], recent defined as \<14 days prior to surgery).
  • \- Patients with contraindications to undergo cardiac magnetic resonance imaging
  • (including claustrophobia and CMR\-incompatible implants).
  • \- Prior adverse reactions to gadolinium\- or iodine\-based contrast agents.
  • \- Moderate\-severely compromised renal function (estimated glomerular filtration
  • \[eGFR] \<45mL/min/kg)

Outcomes

Primary Outcomes

Not specified

Similar Trials